1,8-Cineole Alleviates PA-Induced Lipid Accumulation, Oxidative Stress, and Inflammation via the TLR4/MyD88/NF-κB Signaling Pathway
Molecules · 2026
DOI: 10.3390/molecules31111933 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Yanlong Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Kunming Medical University, Kunming 650500, China. Hauptthemen laut MEDLINE: Oxidative Stress, Toll-Like Receptor 4, Myeloid Differentiation Factor 88, Signal Transduction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Program of Yunnan Provincial Science and Technology Department.
Abstract (Originalsprache)
Objective
The present study investigates the effect of 1,8-cineole on improving lipid metabolism disorder by regulating oxidative stress and inflammation via the TLR4/MyD88/NF-κB pathway. 1,8-Cineole is a monoterpene compound widely found in the essential oils of many plants and has been reported to possess anti-inflammatory and antioxidant activities. However, its role in regulating lipid metabolism disorders remains unclear. This study aimed to investigate the effects of 1,8-cineole on lipid metabolism and explore the potential mechanisms related to oxidative stress and inflammation.
Methods
Cell viability was assessed by MTT assay to determine the optimal PA concentration for inducing lipid accumulation and the non-cytotoxic range of 1,8-cineole in HepG2 and AML-12 cells. Lipid droplets were visualized by Oil Red O staining, while triglyceride (TG) and total cholesterol (TC) levels were quantified using enzymatic kits. Oxidative stress markers (ROS by DCFH-DA fluorescence; MDA by TBA method; CAT activity by ammonium molybdate method) and inflammatory cytokines (TNF-α, IL-6, IL-1β, IL-18 by ELISA) were measured. Western blotting analyzed key proteins in the TLR4/MyD88/NF-κB pathway (TLR4, MyD88, p-P65, p-IκBα). Pathway-specific inhibitors were employed for mechanistic validation.
Results
1,8-Cineole (up to 1000 μg/mL) showed no cytotoxicity. It significantly attenuated PA-induced lipid droplet accumulation, reduced TG and TC levels (p < 0.05), and ameliorated oxidative stress by decreasing ROS and MDA while enhancing CAT activity in AML-12 cells (p < 0.01). Furthermore, 1,8-cineole suppressed pro-inflammatory cytokine release (TNF-α, IL-6, and IL-1β; p < 0.01), whereas no significant effect was observed on IL-18 levels. Downregulated TLR4/MyD88/NF-κB pathway activation. Inhibition of TLR4 or NF-κB mirrored these protective effects.
Conclusions
1,8-Cineole alleviates PA-induced lipid metabolism disorders, oxidative stress, and inflammation in hepatocytes, likely through suppression of the TLR4/MyD88/NF-κB signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, Kunming Medical University, Kunming 650500, China.
- Experiment Center for Medicial Science Research, Kunming Medical University, Kunming 650500, China.
Förderung
- Science and Technology Program of Yunnan Provincial Science and Technology Department
Zitieren
APA
Li, Y., Zhan, A., Zhang, X., Duan, Y., Tang, J., Bai, H., & Wang, Q. (2026). 1,8-Cineole Alleviates PA-Induced Lipid Accumulation, Oxidative Stress, and Inflammation via the TLR4/MyD88/NF-κB Signaling Pathway. Molecules. https://doi.org/10.3390/molecules31111933
Vancouver
Li Y, Zhan A, Zhang X, Duan Y, Tang J, Bai H, et al. 1,8-Cineole Alleviates PA-Induced Lipid Accumulation, Oxidative Stress, and Inflammation via the TLR4/MyD88/NF-κB Signaling Pathway. Molecules. 2026. doi:10.3390/molecules31111933
BibTeX
@article{Li2026,
author = {Li, Yanlong and Zhan, Anning and Zhang, Xiaobing and Duan, Yu and Tang, Jiawen and Bai, Hua and Wang, Qi},
title = {1,8-Cineole Alleviates PA-Induced Lipid Accumulation, Oxidative Stress, and Inflammation via the TLR4/MyD88/NF-κB Signaling Pathway},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31111933}
}
EUVIMED